Cargando…
Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790333/ https://www.ncbi.nlm.nih.gov/pubmed/33415358 http://dx.doi.org/10.1007/s00417-020-05042-7 |
| _version_ | 1783633401377456128 |
|---|---|
| author | Korobelnik, Jean-François Loewenstein, Anat |
| author_facet | Korobelnik, Jean-François Loewenstein, Anat |
| author_sort | Korobelnik, Jean-François |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7790333 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77903332021-01-08 Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update Korobelnik, Jean-François Loewenstein, Anat Graefes Arch Clin Exp Ophthalmol Letter to the Editor Springer Berlin Heidelberg 2021-01-07 2021 /pmc/articles/PMC7790333/ /pubmed/33415358 http://dx.doi.org/10.1007/s00417-020-05042-7 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter to the Editor Korobelnik, Jean-François Loewenstein, Anat Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update |
| title | Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update |
| title_full | Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update |
| title_fullStr | Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update |
| title_full_unstemmed | Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update |
| title_short | Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update |
| title_sort | communicating with patients requiring anti-vegf intravitreal injections and their families during the covid-19 pandemic: an update |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790333/ https://www.ncbi.nlm.nih.gov/pubmed/33415358 http://dx.doi.org/10.1007/s00417-020-05042-7 |
| work_keys_str_mv | AT korobelnikjeanfrancois communicatingwithpatientsrequiringantivegfintravitrealinjectionsandtheirfamiliesduringthecovid19pandemicanupdate AT loewensteinanat communicatingwithpatientsrequiringantivegfintravitrealinjectionsandtheirfamiliesduringthecovid19pandemicanupdate AT communicatingwithpatientsrequiringantivegfintravitrealinjectionsandtheirfamiliesduringthecovid19pandemicanupdate |